Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 0.39 |
| ▸ | CA1 | P00915 | 4/20 | 0.39 |
| ▸ | CA2 | P00918 | 4/20 | 0.39 |
| ▸ | CA4 | P22748 | 4/20 | 0.39 |
| ▸ | CA9 | Q16790 | 4/20 | 0.39 |
| ▸ | PDE5A | O76074 | 1/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nitric Acid SCHEMBL2481069 | 0.94 | CA12 (0.36) | CA12CA1CA2CA4CA9 | |
| SCHEMBL221310 | 0.93 | — | — | |
| Nitric Acid SCHEMBL4961752 | 0.88 | CA12 (0.33) | CA12CA1CA2CA4CA9 | |
| SCHEMBL3863882 | 0.84 | — | — | |
| SCHEMBL1220763 | 0.81 | CA12 (0.48) | CA12CA1CA2CA4CA9 | |
| Nitric Acid SCHEMBL219749 | 0.78 | MEN1 (0.36) | ALDH1A1 | |
| SCHEMBL25180667 | 0.78 | CA12 (0.50) | CA12CA1CA2CA4CA9 | |
| SCHEMBL25180691 | 0.78 | CA12 (0.50) | CA12CA1CA2CA4CA9 | |
| SCHEMBL8957403 | 0.78 | CA12 (0.50) | CA12CA1CA2CA4CA9 | |
| SCHEMBL1842696 | 0.78 | CA12 (0.50) | CA12CA1CA2CA4CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2377855-B1 | A valsartanamide dinitrate derivative for the treatment of vascular and metabolic diseases | CARDIOLYNX AG (CH) | 2012-07-18 | — | — | EP | disclosed |
| EP-2377855-A1 | A valsartanamide dinitrate derivative for the treatment of vascular and metabolic diseases | Cardiolynx AG (CH) | 2011-10-19 | — | — | EP | disclosed |